For years, people have talked about the physical side effects of GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound.
Nausea. Weight loss. Food noise disappearing.
But now another conversation is starting to happen online and in doctors’ offices: some people say they feel emotionally… flat.
It’s being called “Ozempic personality,” and while doctors stress that it’s not an official diagnosis, enough patients are reporting it that experts are paying attention.
Some users describe losing interest in things they once loved:
- going out to dinner
- shopping
- socializing
- sports
- dating
- even hobbies they used to be obsessed with
One man interviewed by TODAY said he realized something was off when he completely stopped caring about baseball, something he had always loved.
Others describe it as:
“The lights dimmed a little.”
And honestly? That description is hitting a nerve with a lot of people.
Doctors say the medical term for this feeling is anhedonia, which basically means a reduced ability to feel pleasure.
The tricky part is that GLP-1 medications don’t just affect appetite. They also appear to impact the brain’s reward system. That may be one reason people suddenly lose interest in emotional eating, alcohol, impulsive shopping, or other dopamine-driven behaviors.
For some people, that feels life changing in a good way.
For others, it can feel like they lost their spark.
And here’s the important part: experts say patients should absolutely speak up if they notice emotional changes, depression, anxiety, numbness, or personality shifts while taking these medications.
In some cases, lowering the dose or changing medications may help.
At the same time, many people on GLP-1s say their mental health has actually improved because they feel healthier, more confident, and less consumed by food thoughts.
So this isn’t a one-size-fits-all story.
But it is a conversation worth having because so many people are quietly asking themselves:
“Am I finally calm… or do I just not feel like myself anymore?”
And that’s a very different question.
